Transactions - JULY 30, 2020

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Tishman Speyer JV makes life science first project in Boston

by Andrea Zander

Breakthrough Properties, a joint venture between Tishman Speyer and Bellco Capital, a biotechnology investment firm, has announced its first project together, The 105, located at 105 West First Street, in Boston’s Seaport Neighborhood.

It is scheduled for completion in early 2022.

Conveniently located near the Red Line’s Broadway Station, it will feature a tailored array of amenities, including a fitness facility and outdoor terraces accessible from two floors. LEED Gold and Fitwel certifications will be sought.

Recently, CRISPR Therapeutics, a gene editing company, signed a 263,500-square-foot lease agreement for the development.

The full-building lease transaction was executed just one year after acquisition of the site in July 2019 and four months after groundbreaking.

Dan Belldegrun, Breakthrough Properties CEO, said, “Our mission at Breakthrough is to deliver cutting edge facilities and environments that support companies at the forefron

Forgot your username or password?

We use cookies and other tracking technologies to personalize your user experience on our site and perform site analytics. By clicking on “I accept”, you consent to our Privacy Policy.